X-CEPTOR THERAPEUTICS, INC.
X-Ceptor Therapeutics, Inc. was acquired by Exelixis, Inc. X-Ceptor Therapeutics, Inc. discovers and develops novel small molecule therapeutics that modulate nuclear receptors. The company offers drug discovery platform for the nuclear receptor gene family; and drug candidates to treat cardiovascular and metabolic disorders.
X-CEPTOR THERAPEUTICS, INC.
Industry:
Biotechnology Therapeutics
Founded:
1999-01-01
Address:
San Diego, California, United States
Country:
United States
Status:
Active
Contact:
(858)458-4500
Similar Organizations
Mitobridge
Mitobridge is discovering and developing small molecule therapeutics that improve mitochondrial functions.
More informations about "X-Ceptor Therapeutics, Inc."
X-Ceptor Therapeutics Company Profile 2024: Valuation, Investors ...
Oct 7, 1999 X-Ceptor Therapeutics has raised $25M. Who are X-Ceptor Therapeutics’s investors? Domain Associates, Farallon Capital Management, Gimv, Le Centre CDP Capital, …See details»
Exelixis acquires X-Ceptor Therapeutics, Inc. - Crunchbase
X-Ceptor Therapeutics, Inc. X-Ceptor Therapeutics, Inc. discovers and develops novel small molecule therapeutics that modulate nuclear receptors. Acquiring Organization: Exelixis …See details»
X-Ceptor Therapeutics Inc - Company Profile and News
Company profile page for X-Ceptor Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
X-Ceptor Therapeutics - Ownership and Business Overview - Mergr
Jan 14, 2005 X-Ceptor Therapeutics was founded in 1999. Life Science M&A Summary in 2005 Out of 60 sectors in the Mergr database, life science ranked 13 in number of deals in 2005 .See details»
EXELIXIS COMPLETES ACQUISITION OF X-CEPTOR - SEC.gov
This press release contains forward-looking statements, including without limitation all statements related to the timing and intended benefits of the acquisition of X-Ceptor Therapeutics, …See details»
X-Ceptor Therapeutics, Inc. - Crunchbase
X-Ceptor Therapeutics, Inc. discovers and develops novel small molecule therapeutics that modulate nuclear receptors.See details»
X-Ceptor Therapeutics - Company Profile - Tracxn
Dec 5, 2024 X-Ceptor Therapeutics - Nuclear receptor modulating small molecule drugs for metabolism and cardiovascular diseases. Acquired by Exelixis. Raised funding over 2 rounds …See details»
X-Ceptor Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Explore X-Ceptor Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 13 literature.See details»
X-Ceptor Therapeutics Inc. - Scrip
Mar 1, 2004 The field of nuclear receptor drug discovery boasts few industrial-strength programs. X-Ceptor Therapeutics Inc., a 1999 spin-out from Ligand Pharmaceuticals Inc., is …See details»
X-Ceptor Therapeutics Inc. - BioCentury Company Profiles - BCIQ
X-Ceptor Therapeutics Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Exelixis Turns X-Ceptor Into Partners: Third Deal Signed
About 18 months ago, South San Francisco-based Exelixis Inc. made a $25.7 million investment when it acquired three preclinical programs through its buyout of X-Ceptor Therapeutics Inc. …See details»
Feeding the Machine: Exelixis Buys X-Ceptor :: In Vivo
Nov 1, 2004 By acquiring X-Ceptor Therapeutics it gets a set of much-needed near-term partnering opportunities, and it did so without significantly increasing its projected burn. …See details»
X-Ceptor Therapeutics - Pappas Capital
X-Ceptor Therapeutics. ← Back to Ventures Portfolio. X-Ceptor focused on the identification of novel drug candidates that interact with orphan nuclear receptors involved in cholesterol …See details»
X-Ceptor Therapeutics, Inc. - Updates, News, Events ... - Crunchbase
X-Ceptor Therapeutics, Inc. discovers and develops novel small molecule therapeutics that modulate nuclear receptors.See details»
Exelixis signs $157M deal to license hormone receptor
Dec 21, 2005 Exelixis won control of the compounds with its 2004 buyout of X-Ceptor Therapeutics. "This transaction with Wyeth is a further demonstration of the quality of our drug …See details»
Sentara Northern Virginia Medical Center names new president
"Following a national search, Sentara is proud to have Jeff Joyner join our organization to lead our operations in the Northern Virginia region," said Paul A. Gaden, Regional President, Western …See details»
330863380 EIN/TAX ID | X-CEPTOR THERAPEUTICS, INC.
X-CEPTOR THERAPEUTICS, INC. Conformed submission company name, business name, organization name, etc CIK: N/S (NOT SPECIFIED) Company's Central Index Key (CIK). The …See details»
The 6th "Golden Central" List Revealed: Global X ETFs Hong Kong …
14 hours ago On the afternoon of December 13, 2024, the 6th "2024 Golden Central Forum and Financial Institutions Award Ceremony" was successfully held in Central, Hong Kong. The …See details»
RAYUS RADIOLOGY - NPI 1255300471 - Radiology in …
Mar 17, 2006 NPI Profile for Rayus Radiology in 4001 Prince William Parkway Suite 104 Woodbridge, Va 22192. Phone: (703) 490-3677 . Taxonomy 2085R0202XSee details»
Staff & Board - SCAN of Northern Virginia
Meet our board. At SCAN, we are committed to our mission.In order to help us fulfill that mission, we have gathered a team of committed professionals who represent excellence and integrity in …See details»